225 related articles for article (PubMed ID: 11270550)
1. MIB-1 staining index of pediatric meningiomas.
Sandberg DI; Edgar MA; Resch L; Rutka JT; Becker LE; Souweidane MM
Neurosurgery; 2001 Mar; 48(3):590-5; discussion 595-7. PubMed ID: 11270550
[TBL] [Abstract][Full Text] [Related]
2. Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas.
Matsuno A; Fujimaki T; Sasaki T; Nagashima T; Ide T; Asai A; Matsuura R; Utsunomiya H; Kirino T
Acta Neuropathol; 1996; 91(5):504-10. PubMed ID: 8740231
[TBL] [Abstract][Full Text] [Related]
3. MIB-1 labeling indices in benign, aggressive, and malignant meningiomas: a study of 90 tumors.
Abramovich CM; Prayson RA
Hum Pathol; 1998 Dec; 29(12):1420-7. PubMed ID: 9865827
[TBL] [Abstract][Full Text] [Related]
4. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.
Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A
Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic validity of the Ki-67 labeling index using the MIB-1 monoclonal antibody in the grading of meningiomas.
Devaprasath A; Chacko G
Neurol India; 2003 Sep; 51(3):336-40. PubMed ID: 14652433
[TBL] [Abstract][Full Text] [Related]
6. Significance of MIB-1 staining indices in meningiomas: comparison of two counting methods.
Nakasu S; Li DH; Okabe H; Nakajima M; Matsuda M
Am J Surg Pathol; 2001 Apr; 25(4):472-8. PubMed ID: 11257621
[TBL] [Abstract][Full Text] [Related]
7. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma.
Ho DM; Hsu CY; Ting LT; Chiang H
Cancer; 2002 Mar; 94(5):1538-47. PubMed ID: 11920512
[TBL] [Abstract][Full Text] [Related]
8. Radiation-associated meningiomas in children: clinical, pathological, and cytogenetic characteristics with a critical review of the literature.
Elbabaa SK; Gokden M; Crawford JR; Kesari S; Saad AG
J Neurosurg Pediatr; 2012 Oct; 10(4):281-90. PubMed ID: 22900483
[TBL] [Abstract][Full Text] [Related]
9. MIB-1 staining index and peritumoral brain edema of meningiomas.
Ide M; Jimbo M; Yamamoto M; Umebara Y; Hagiwara S; Kubo O
Cancer; 1996 Jul; 78(1):133-43. PubMed ID: 8646709
[TBL] [Abstract][Full Text] [Related]
10. Histopathologic features and MIB-1 labeling indices in recurrent and nonrecurrent meningiomas.
Abramovich CM; Prayson RA
Arch Pathol Lab Med; 1999 Sep; 123(9):793-800. PubMed ID: 10458826
[TBL] [Abstract][Full Text] [Related]
11. Correlation between histological grade, MIB-1, p53, and recurrence in 69 completely resected primary intracranial meningiomas with a 6 year mean follow-up.
Lanzafame S; Torrisi A; Barbagallo G; Emmanuele C; Alberio N; Albanese V
Pathol Res Pract; 2000; 196(7):483-8. PubMed ID: 10926326
[TBL] [Abstract][Full Text] [Related]
12. Meningioma: proliferating potential and clinicoradiological features.
Nakasu S; Nakajima M; Matsumura K; Nakasu Y; Handa J
Neurosurgery; 1995 Dec; 37(6):1049-55. PubMed ID: 8584144
[TBL] [Abstract][Full Text] [Related]
13. [Estrogen and progesterone receptors in meningiomas: immunohistochemical (Mib-1, p53) and clinico-morphological correlations].
Taddei GL; Caldarella A; Raspollini MR; Taddei A; Buccoliero AM
Pathologica; 2002 Feb; 94(1):10-5. PubMed ID: 11912872
[TBL] [Abstract][Full Text] [Related]
14. The prognostic significance of MIB-1, p53, and DNA flow cytometry in completely resected primary meningiomas.
Perry A; Stafford SL; Scheithauer BW; Suman VJ; Lohse CM
Cancer; 1998 Jun; 82(11):2262-9. PubMed ID: 9610708
[TBL] [Abstract][Full Text] [Related]
15. Potential doubling time and tumour doubling time in meningiomas and neurinomas.
Nakasu S; Nakasu Y; Nakajima M; Yokoyama M; Matsuda M; Handa J
Acta Neurochir (Wien); 1996; 138(6):763-70. PubMed ID: 8836295
[TBL] [Abstract][Full Text] [Related]
16. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.
Shino A; Nakasu S; Matsuda M; Handa J; Morikawa S; Inubushi T
J Neurosurg; 1999 Dec; 91(6):928-34. PubMed ID: 10584837
[TBL] [Abstract][Full Text] [Related]
17. The significance of nucleolar organizer region (AgNOR) score in predicting meningioma recurrence.
Kunishio K; Ohmoto T; Matsuhisa T; Maeshiro T; Furuta T; Matsumoto K
Cancer; 1994 Apr; 73(8):2200-5. PubMed ID: 8156526
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of MIB-1, p53, and bcl-2 immunoreactivity in meningiomas.
Karamitopoulou E; Perentes E; Tolnay M; Probst A
Hum Pathol; 1998 Feb; 29(2):140-5. PubMed ID: 9490273
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical analysis of p16INK4a, p14ARF, p18INK4c, p21CIP1, p27KIP1 and p73 expression in 271 meningiomas correlation with tumor grade and clinical outcome.
Korshunov A; Shishkina L; Golanov A
Int J Cancer; 2003 May; 104(6):728-34. PubMed ID: 12640680
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of proliferation index and expression of the RNA component of human telomerase (hTR) in papillary meningiomas.
Rushing EJ; Colvin SM; Gazdar A; Miura N; White CL; Coimbra C; Burns DK
J Neurooncol; 1999; 45(3):199-207. PubMed ID: 10845390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
